Clinical Trial Update: A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris [Phase 3]

View source ↗

Summary

Phase 3 trial in Chinese subjects with acne vulgaris to compare the efficacy, safety and pharmacokinetics of trifarotene 50 mcg/g cream. The study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Trifarotene 50 mcg/g Cream (trifarotene)

Snippet

Sponsor: Galderma R&D | Conditions: Acne Vulgaris | Phase 3 | Status: RECRUITING